AstraZeneca and Daiichi Sankyo’s Enhertu Improves PFS in First-Line HER2-Mutant Advanced NSCLC in Phase III DESTINY-Lung04
International Urology Cancer Summit and OncoDaily Announce Strategic Partnership
Using Lung Function Data to Refine Pulmonary Toxicity Risk Before Thoracic Radiotherapy
Evelyn H. Lauder at 90: A Legacy That Transformed Breast Cancer Research
10 Must-Read Posts In GU Oncology This Week
AstraZeneca Discontinues Phase III eVOLVE-Lung02 Trial of Volrustomig Plus Chemotherapy in Metastatic NSCLC
Vivek Subbiah: Rethinking the Unified Cancer of Unknown Primary Concept
DESTINY-Lung04: Enhertu Improves First-Line PFS in HER2-Mutant NSCLC
The 2027 Community Oncology Conference, organized by the Community Oncology Alliance (COA), will take place on April 6–7, 2027 in Lake Buena Vista, Florida. The annual conference brings together professionals from across community oncology to discuss issues affecting cancer care, practice operations, policy, innovation, and the future of community-based oncology. The meeting will be held […]
